Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Dent

Showing results (91-100 of 395) with videos related to

Pageof 40
Sort By:
Cancer Biology & Therapy|February 22, 2014
Pazopanib and HDAC inhibitors interact to kill sarcoma cellsSeyedmehrad Tavallai, Hossein A Hamed, Steven Grant, et al.
Oncotarget|November 16, 2017
HDAC inhibitors enhance the immunotherapy response of melanoma cellsLaurence Booth, Jane L Roberts, Andrew Poklepovic, et al.
Cancer Biology & Therapy|November 4, 2018
Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibitionLaurence Booth, Jane L Roberts, Sarah Spiegel, et al.
Molecular Pharmacology|August 31, 2006
Dissecting the roles of checkpoint kinase 1/CDC2 and mitogen-activated protein kinase kinase 1/2/extracellular signal-regulated kinase 1/2 in relation to 7-hydroxystaurosporine-induced apoptosis in human multiple myeloma cellsXin-Yan Pei, Weiqun Li, Yun Dai, et al.
Cancer Biology & Therapy|August 13, 2002
Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosisRoy H Decker, Shujie Wang, Yun Dai, et al.
Blood|March 25, 2004
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanismsYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Oncotarget|December 2, 2016
PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxideLaurence Booth, Jane L Roberts, Andrew Poklepovic, et al.
The Journal of Biological Chemistry|June 4, 2004
A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2Yun Dai, Mohamed Rahmani, Seth J Corey, et al.
Gene|March 23, 2005
Characterization of Cdk9(55) and differential regulation of two Cdk9 isoformsSarah M Shore, Sarah A Byers, Paul Dent, et al.
Blood|January 16, 2007
MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825Tri K Nguyen, Mohamed Rahmani, Hisashi Harada, et al.
Pageof 40

Showing results (91-100 of 395) with videos related to

Sort By:
Pageof 40
Cancer Biology & Therapy|February 22, 2014
Pazopanib and HDAC inhibitors interact to kill sarcoma cellsSeyedmehrad Tavallai, Hossein A Hamed, Steven Grant, et al.
Oncotarget|November 16, 2017
HDAC inhibitors enhance the immunotherapy response of melanoma cellsLaurence Booth, Jane L Roberts, Andrew Poklepovic, et al.
Cancer Biology & Therapy|November 4, 2018
Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibitionLaurence Booth, Jane L Roberts, Sarah Spiegel, et al.
Molecular Pharmacology|August 31, 2006
Dissecting the roles of checkpoint kinase 1/CDC2 and mitogen-activated protein kinase kinase 1/2/extracellular signal-regulated kinase 1/2 in relation to 7-hydroxystaurosporine-induced apoptosis in human multiple myeloma cellsXin-Yan Pei, Weiqun Li, Yun Dai, et al.
Cancer Biology & Therapy|August 13, 2002
Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosisRoy H Decker, Shujie Wang, Yun Dai, et al.
Blood|March 25, 2004
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanismsYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Oncotarget|December 2, 2016
PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxideLaurence Booth, Jane L Roberts, Andrew Poklepovic, et al.
The Journal of Biological Chemistry|June 4, 2004
A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2Yun Dai, Mohamed Rahmani, Seth J Corey, et al.
Gene|March 23, 2005
Characterization of Cdk9(55) and differential regulation of two Cdk9 isoformsSarah M Shore, Sarah A Byers, Paul Dent, et al.
Blood|January 16, 2007
MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825Tri K Nguyen, Mohamed Rahmani, Hisashi Harada, et al.
Pageof 40